Primary Tumor-Related Complications and Salvage Outcomes in Patients with Metastatic Rectal Cancer and an Untreated Primary Tumor

被引:6
|
作者
Tan, Winson J. [1 ,2 ]
Patil, Sujata [3 ]
Guillem, Jose G. [1 ]
Paty, Philip B. [1 ]
Weiser, Martin R. [1 ]
Nash, Garrett M. [1 ]
Smith, J. Joshua [1 ]
Pappou, Emmanouil P. [1 ]
Wei, Iris H. [1 ]
Garcia-Aguilar, Julio [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Colorectal Serv, Dept Surg, 1275 York Ave, New York, NY 10065 USA
[2] Sengkang Gen Hosp, Dept Gen Surg, Singapore, Singapore
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Complications; Metastasis; Rectal cancer; Salvage; Untreated primary tumor; IV COLORECTAL-CANCER; RECEIVING CHEMOTHERAPY; RESECTION; SURVIVAL; METAANALYSIS; SURGERY; THERAPY; COLON;
D O I
10.1097/DCR.0000000000001803
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: For rectal cancer with unresectable metastases, current practice favors omitting interventions directed at the primary tumor in asymptomatic patients. OBJECTIVE: This study aimed to determine the proportion of patients with primary tumor-related complications, characterize salvage outcomes, and measure survival in patients with metastatic rectal cancer who did not undergo upfront intervention for their primary tumor. DESIGN: This is a retrospective analysis. SETTING: This study was conducted at a comprehensive cancer center. PATIENTS: Patients who presented between January 1, 2008, and December 31, 2015, with synchronous stage IV rectal cancer, an unresected primary tumor, and no prior primary tumor-directed intervention were selected. MAIN OUTCOME MEASURES: The main outcome measured was the rate of primary tumor-related complications in the cohort that did not receive any primary tumor-directed intervention. The Kaplan-Meier method and Cox regression analysis were used to determine whether complications are associated with survival. RESULTS: The cohort comprised 358 patients with a median age of 56 years (22-92). Median follow-up was 26 months (range, 1-93 months). Among the 168 patients (46.9%) who eventually underwent elective resection of the primary tumor, the surgery was performed with curative intent in 66 patients (18.4%) and preemptive intent in 102 patients (28.5%). Of the 190 patients who did not undergo an upfront or elective intervention for the primary tumor, 68 (35.8%) experienced complications. Nonsurgical intervention for complications was attempted in 34 patients with an overall success rate of 61.8% (21/34). Surgical intervention was performed in 47 patients (including 13 patients for whom nonsurgical intervention failed): diversion in 26 patients and resection in 21 patients. Of those 47 patients, 42 (89.4%) ended up with a colostomy or ileostomy. LIMITATIONS: This study was conducted at a single center. CONCLUSION: A significant proportion of patients with metastatic rectal cancer and untreated primary tumor experience primary tumor-related complications. These patients should be followed closely, and preemptive intervention (resection, diversion, or radiation) should be considered if the primary tumor progresses despite systemic therapy.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [21] Primary tumor resection improves the survival of younger patients with metastatic breast cancer
    Shien, Tadahiko
    Kinoshita, Takayuki
    Shimizu, Chikako
    Hojo, Takashi
    Taira, Naruto
    Doihara, Hiroyoshi
    Akashi-Tanaka, Sadako
    ONCOLOGY REPORTS, 2009, 21 (03) : 827 - 832
  • [22] Osteochondroma: MR imaging of tumor-related complications
    Woertler, K
    Lindner, N
    Gosheger, G
    Brinkschmidt, C
    Heindel, W
    EUROPEAN RADIOLOGY, 2000, 10 (05) : 832 - 840
  • [23] Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients
    Rosa, Consuelo
    Di Tommaso, Monica
    Caravatta, Luciana
    Taraborrelli, Maria
    Gasparini, Lucrezia
    Di Guglielmo, Fiorella Cristina
    Pizzi, Andrea Delli
    Cinalli, Sebastiano
    Marchioni, Michele
    Di Nicola, Marta
    Lanci, Carmine
    Cefaro, Giampiero Ausili
    Genovesi, Domenico
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (04) : 1179 - 1188
  • [24] Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Shu, Yefei
    Xu, Ling
    Yang, Wei
    Xu, Xiaofeng
    Zheng, Song
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Tumor recurrence and tumor-related mortality in endometrial cancer: Analysis in 276 patients
    Tejerizo-Garcia, A.
    Alvarez-Conejo, C.
    Munoz-Hernando, L.
    Guillen-Gamez, C.
    Seoane-Ruiz, J. M.
    Perez-Sagaseta, C.
    Jimenez-Lopez, J. S.
    INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 682 - 684
  • [26] Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer
    Wu, Jiayan
    Zheng, Haosheng
    Wang, Gengfeng
    Qin, Fei
    Zheng, Yuzhen
    Chen, Junguo
    Liu, Zui
    Jian, Bozhu
    Qin, Xianyu
    Liao, Hongying
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer
    Tralhao, J. G.
    Hoti, E.
    Serodio, M.
    Laranjeiro, P.
    Paiva, A.
    Abrantes, A. M.
    Pais, M. L.
    Botelho, M. F.
    Sousa, F. Castro
    EJSO, 2010, 36 (02): : 125 - 129
  • [28] Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
    Criscitiello, C.
    Giuliano, M.
    Curigliano, G.
    De Laurentiis, M.
    Arpino, G.
    Carlomagno, N.
    De Placido, S.
    Golshan, M.
    Santangelo, M.
    EJSO, 2015, 41 (10): : 1288 - 1292
  • [29] Identifying optimal candidates for primary tumor surgery in patients with metastatic head and neck cancer
    Liang, Qi-Wei
    Zhuang, Shuang-Hao
    Li, Sheng
    FRONTIERS IN SURGERY, 2024, 11
  • [30] Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients
    Paradiso, A
    Tommasi, S
    Barletta, A
    Leone, B
    Lacava, J
    Vellejo, C
    Labriola, A
    Marzullo, F
    Altieri, R
    Schittulli, F
    De Lena, M
    ANTICANCER RESEARCH, 1999, 19 (5C) : 4523 - 4528